Combination of ibrutinib and chemotherapy produced a durable remission in multiply relapsed diffuse large B-cell lymphoma leg type with mutant and wildtype .
Andrew L Deng, Yu Ri Kim, Emily A Lichtenstein, Owen A O'Connor, Changchun Deng
Author Information
- Andrew L Deng: Columbia University Medical Center, Center for Lymphoid Malignancies, New York, NY, USA.
- Yu Ri Kim: Columbia University Medical Center, Center for Lymphoid Malignancies, New York, NY, USA.
- Emily A Lichtenstein: Columbia University Medical Center, Center for Lymphoid Malignancies, New York, NY, USA.
- Owen A O'Connor: Columbia University Medical Center, Center for Lymphoid Malignancies, New York, NY, USA.
- Changchun Deng: Columbia University Medical Center, Center for Lymphoid Malignancies, New York, NY, USA cd2448@columbia.edu.
No abstract text available.
- Nat Med. 2015 Aug;21(8):922-6
[PMID: 26193343]
- Nature. 2011 Feb 3;470(7332):115-9
[PMID: 21179087]
- N Engl J Med. 2012 Aug 30;367(9):826-33
[PMID: 22931316]
- J Invest Dermatol. 2014 Jan;134(1):290-292
[PMID: 23863863]
- Blood. 2013 Aug 15;122(7):1222-32
[PMID: 23836557]
- Blood Cancer J. 2013 Sep 06;3:e139
[PMID: 24013661]
- Neurology. 2017 Jan 3;88(1):101-102
[PMID: 27864520]
- N Engl J Med. 2015 Aug 6;373(6):584-6
[PMID: 26244327]
Adenine
Aged
Antineoplastic Combined Chemotherapy Protocols
CD79 Antigens
Female
Humans
Immunophenotyping
Lymphoma, Large B-Cell, Diffuse
Mutation
Myeloid Differentiation Factor 88
Piperidines
Positron Emission Tomography Computed Tomography
Pyrazoles
Pyrimidines
Recurrence
Retreatment
Treatment Outcome
CD79 Antigens
Myeloid Differentiation Factor 88
Piperidines
Pyrazoles
Pyrimidines
ibrutinib
Adenine
